Timber Pharmaceuticals, Inc.
AMEX: TMBR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Koconis
- Employees
- 9
- Headquarters
- Basking Ridge, United States
- IPO year
- 2014
- Market cap
- $1.2M
- Website
- https://www.timberpharma.com
Loading TMBR…
Loading profile data…Frequently asked questions about TMBR
What does Timber Pharmaceuticals, Inc. (TMBR) do?
Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions. The company's key product candidates include: TMB-001, a patented topical isotretinoin formulation, which has successfully completed Phase 2b cli...
Where does TMBR trade?
Timber Pharmaceuticals, Inc. (TMBR) trades on the New York Stock Exchange Arca.
What sector is TMBR in?
Timber Pharmaceuticals, Inc. (TMBR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Timber Pharmaceuticals, Inc.?
John Koconis is the chief executive officer of Timber Pharmaceuticals, Inc. (TMBR).
Where is Timber Pharmaceuticals, Inc. headquartered?
Timber Pharmaceuticals, Inc. is headquartered in United States.
Does TMBR pay a dividend?
Timber Pharmaceuticals, Inc. (TMBR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TMBR go public?
Timber Pharmaceuticals, Inc. (TMBR) completed its initial public offering in 2014.